US security policy in Latin America and the Caribbean under President Trump has moved towards a militarized and repressive ...

As CRISPR moves from lab success to real-world medicine, 2026 will test whether these revolutionary gene-editing therapies ...

Insilico now has a pipeline of more than 40 AI-developed drugs it is developing for conditions such as cancer, bowel and kidney disease.

NorthStar Medical Radioisotopes, LLC (NorthStar), a leading radiopharmaceutical company, today confirmed that it has been ...

Zebrafish (Danio Rerio) have emerged as a powerful bioengineering platform for next-generation drug discovery, offering an unparalleled combination of ...

St. Luke’s playbook building future pharmacy model details automation and AI strategies to enhance patient access and speed in Idaho health system.

In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...

CMS has launched the BALANCE Model, a five-year test to lower costs & expand Medicare access to GLP-1 weight-loss drugs while ...

The sheer growth of small biotechs and mid‑sized pharma companies entering the field has reshaped expectations of Contract ...

Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

PEGASUS generates permeable macrocyclic peptides, offering new promise for a modality that can combine the properties of a biologic in a pill ...

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and ...